Viamet Pharmaceuticals, Inc.

Release Summary

Viamet Pharmaceuticals, Inc. today reported positive results from RENOVATE, its Phase 2b clinical trial of VT-1161 in onychomycosis of the large toenail.

Viamet Pharmaceuticals, Inc.